In patients with lung cancer‐related cachexia, AKT activation is increased without concurrent activation of MTOR or its downstream targets.41 This may indicate that, although impaired AKT signalling is found in lung cancer cachexia, AKT signalling is largely intact in COPD‐induced muscle wasting. The gene discussed is AKT1; the disease is Cachexia.